Yahoo Web Search

Search results

1. • 

     3 Biotech Stocks That Could Be Millionaire-Makers: May Edition

     InvestorPlace· 1 day ago

     As we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused...

2. • 

     This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...

     CNBC· 3 days ago

     Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...

3. • 

     Docs support drug regulator’s move to withdraw Olaparib for some cancer patients

     Investing.com· 4 days ago

     Olaparib is a chemotherapy drug and is used to treat certain kinds of cancers of the ovaries,...

4. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 3 days ago

     “We are excited to announce that FG-3246 in combination with enzalutamide in patients with mCRPC...

5. • 

     Candel (CADL) Reports Upbeat Data From Lung Cancer Study

     Zacks via Yahoo Finance· 2 days ago

     Candel's (CADL) CAN-2409 prolongs overall survival in a phase II study for treating patients with...

6. • Support Early Detection Technology to Save the Lives of Black Cancer Patients - Los Angeles Sentinel

     Los Angeles Sentinel· 4 days ago

     The stark reality that Black women are 41% more likely to die from breast cancer than White women is a grim reminder of the systemic inequities that pervade our health care ...

7. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 3 days ago

     SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies at the 2024 ASCO Annual Meeting. Three studies

8. • 

     NCI-MATCH Precision Medicine Clinical Trial

     National Cancer Institute· 3 days ago

     NCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...

9. • Candel (CADL) Reports Upbeat Data From Lung Cancer Study

     Zacks· 3 days ago

     Candel's (CADL) CAN-2409 prolongs overall survival in a phase II study for treating patients with advanced non-small cell lung cancer who are non-responsive to immune checkpoint inhibitor therapy.

10. • Drug Discovery, Development and Evaluation Hub Welcomes New Faculty to Fuel Innovation

      UB Reporter· 6 days ago

      The University at Buffalo School of Pharmacy and Pharmaceutical Sciences’ (UB SPPS) Drug Discovery, Development and Evaluation (DDDE) Hub, a leading research engine in the fields of pharmaceutical ...